A tape measure outpredicted epigenetic clocks in a Finnish cohort

August 19, 2026 · Science · Biological age

What the study found

Researchers at Tampere University report that a statistical model built from four conventional risk factors — body mass index, waist-to-hip ratio, smoking and alcohol consumption — predicted the onset of chronic non-communicable disease more accurately than any of the epigenetic clocks they analyzed. The paper, "Traditional Disease Risk Factors Outperform Epigenetic Clocks as Predictors of Non-Communicable Disease Morbidity in a Middle-Aged Cohort," was published in Aging Cell on July 9, 2026 (DOI 10.1111/acel.70626). The analysis drew on the Cardiovascular Risk in Young Finns Study (LASERI), a cohort running since 1980, and included 1,108 participants who were aged 34 to 49 at baseline and free of chronic disease diagnoses at enrollment, followed for 7 to 9 years. First author Daria Kostiniuk is a doctoral researcher; the study was led by senior research fellow Saara Marttila.

What it means for you

If you are weighing a methylation test, the useful takeaway is a question to put to the vendor rather than a verdict on the category. Most vendor science pages cite studies establishing that clocks are associated with mortality or disease across large populations. Those results are real. They are also a different claim from the one that justifies the purchase, which is that this number tells you something your weight, your waist, your smoking history and a standard blood panel do not already say. This paper tested that second claim directly, in a single cohort, and the cheap measurements won.

The researchers made the same point in methodological terms: a clock may identify a statistically significant risk of future disease without thereby being the better predictor, and tests marketed as transformative ought to demonstrate additional value over established risk factors. That is a fair standard to hold a self-pay test to, and it is the standard our guide to biological age tests already applies when it separates population-level validation from individual-level usefulness. Nothing here changes what those products measure or how to read a report; it sharpens what to expect the number to be good for. If your goal is a risk estimate you can act on, the four inputs in this model are free, immediate, and modifiable — which is a rare combination in this field.

Read the scope honestly before generalizing. This was one Finnish cohort of middle-aged adults, 1,108 people, followed for under a decade, testing prediction of incident chronic disease — not mortality, not healthspan, not response to an intervention. An observational cohort shows which measurements track with later outcomes; it cannot establish that any of them cause disease, and it cannot tell you how a clock would perform in an older population, over 20 years, or against a different endpoint. A single study that cuts against a marketing claim deserves the same scrutiny as a single study that supports one.

How this fits what we already know

Our biological age hub has held a two-part position: the population-level science behind second-generation clocks is genuine, while individual-level precision is weaker than the marketing implies. This study adds a third element that neither half covered — the comparison against conventional risk factors — and it is the element a buyer's decision actually turns on. It does not contradict our TruDiagnostic review or the reasons that product runs several models rather than one; the clocks in question still measure what they measure. What it changes is the burden of proof a vendor should be expected to meet. We will fold the comparative framing into the biological-age guides on their next review cycle rather than restating a single cohort as settled fact.

Sources

• Tampere University, "Risk factors beat pricey tests in predicting illness," university release as published at miragenews.com (accessed August 19, 2026).
• MedicalXpress, "Scales and a measuring tape can predict future illness better than expensive biological age tests," medicalxpress.com, August 18, 2026.
• Kostiniuk D. et al., "Traditional Disease Risk Factors Outperform Epigenetic Clocks as Predictors of Non-Communicable Disease Morbidity in a Middle-Aged Cohort," Aging Cell, July 9, 2026, DOI 10.1111/acel.70626.